Rayner Surgical Group

What Rayner Surgical Group does

Rayner Surgical Group is a British medical device manufacturer specializing in ophthalmic solutions for cataract and refractive surgery, founded in 1949 when Sir Harold Ridley implanted the world's first intraocular lens (IOL). The company manufactures a complete cataract surgery portfolio from its Worthing, West Sussex headquarters — the only IOL manufacturing facility in the UK — including the RayOne family of IOLs (EMV extended range of focus, Trifocal, Monofocal, Toric) and the RayOne preloaded injector, the Sophi wireless phacoemulsification system (acquired from Swiss startup This AG in January 2024), the OMIDRIA intraocular pharmaceutical (phenylephrine/ketorolac), ophthalmic viscosurgical devices, and the AEON artificial tears line. It produces over 1 million IOLs annually and has shipped 400,000+ RayOne EMV lenses to more than 65 countries.

Rayner monetizes primarily through direct and distributor-led hardware sales of IOLs and capital equipment to ophthalmic clinics, hospitals, and cataract surgeons across 80+ countries, with direct sales offices in 15+ markets (UK, USA, Canada, Germany, Austria, France, Italy, Spain, Portugal, Poland, Australia, India, Brazil, Switzerland, Ireland). A growing recurring revenue layer is being built through the RayPRO patient-reported outcomes platform and the eyejourney AI-based patient engagement and consent platform (developed by its Innoptix digital arm), priced at $2,800-$9,000 per clinic on multi-year subscriptions. The company is privately held under CVC Capital Partners and GBL (which took a 45% stake for €500M in February 2026), employs 950+ people globally, and is expanding internationally through both organic launches and bolt-on acquisitions.

Name

Rayner Surgical Group

Legal name

Rayner Surgical Group Limited

Website

http://www.rayner.com/

Company type

Private

Founded year

1910

Operating status

Operating

Headcount range

251–500 employees

Short description

Rayner Surgical Group is a British medical device manufacturer that produces intraocular lenses, the Sophi phacoemulsification system, ophthalmic pharmaceuticals, and AI-enabled patient engagement platforms for ophthalmic clinics, hospitals, and cataract surgeons across 80+ countries.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)

Keywords

• Intraocular lenses
• Ophthalmic medical devices
• Cataract surgery products
• Phacoemulsification systems
• Ophthalmic pharmaceuticals

Headquarters

HQ city

Worthing

HQ country

United Kingdom

HQ region

Europe

Offices16 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Intraocular Lenses (IOLs): Sale of intraocular lenses including RayOne family (EMV, Monofocal, Trifocal, Toric), supplementary lenses, and Galaxy preloaded injector system. Products sold directly and through distributors globally.
2. Sophi Phacoemulsification System: Capital equipment sales including the Sophi wireless phaco system for cataract surgery, along with consumables.
3. OMIDRIA Pharmaceutical: Sale of OMIDRIA ophthalmic pharmaceutical product for use during cataract surgery.
4. Digital Platform Subscriptions: eyejourney AI platform with clinic pricing ranging from $2,800 to $9,000 depending on setup plans.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Rayner Surgical Group manufactures and sells intraocular lenses (IOLs) including the RayOne family (EMV, Trifocal, Monofocal, Toric), the Sophi wireless phacoemulsification system for cataract surgery, the OMIDRIA ophthalmic pharmaceutical for use during cataract procedures, and digital platforms (RayPRO and eyejourney AI platform) that support ophthalmic clinics and surgeons.

Product overview

Rayner Surgical Group is a British medical device manufacturer specializing in ophthalmic solutions with over 70 years of history. The company operates a diversified portfolio organized around surgical devices, pharmaceuticals, and digital platforms. The core product lines include the RayOne family of intraocular lenses (IOLs) - spanning RayOne EMV (extended range of focus), RayOne Trifocal, RayOne Monofocal, and the RayOne Injector system - representing the company's flagship surgical device offerings. The Sophi Phacoemulsification System, acquired from Swiss company This AG in 2024, provides advanced wireless phaco technology for cataract surgery. The pharmaceutical portfolio centers on OMIDRIA, an intraocular solution for pupil dilation and pain reduction during surgery. Digital platforms include RayPRO for patient-reported outcomes collection over three years, and eyejourney, an AI-powered patient education and engagement platform developed by Rayner's Innoptix digital division. Additional offerings include OVDs (ophthalmic viscosurgical devices), artificial tears (AEON family), HASA contact lenses, and Raytrace biometry software. The company manufactures at its Worthing, UK facility and sells products in over 80 countries through distributors and direct sales offices.

Differentiator

Problem solved

Functional benefit

Brands

• RayOne: Family of intraocular lenses including EMV, Trifocal, Monofocal, and Toric variants, along with the RayOne Injector system.
• Sophi
• Omidria
• RayPro
• HASA Optix
• Innoptix
• Raytrace
• RayOne EMV
• Galaxy
• AEON

Products and services

• RayOne EMV Extended range of focus intraocular lens with patented non-diffractive optic profile using controlled positive spherical aberration, designed for cataract surgeons seeking monofocal-level contrast sensitivity with extended depth of focus.
• RayOne Trifocal Trifocal intraocular lens providing vision correction at distance, intermediate, and near ranges for cataract and refractive lens exchange patients.
• RayOne Monofocal Standard monofocal intraocular lens for cataract surgery providing single-distance vision correction.
• RayOne Injector Preloaded injector system for IOL delivery during cataract surgery, offering streamlined intraocular lens implantation.
• Sophi Phacoemulsification System Wireless battery-based phacoemulsification device for cataract surgery featuring a triple pump fluidics system designed to improve anterior chamber stability and surgical efficiency.
• OMIDRIA Intraocular solution containing phenylephrine and ketorolac for use during cataract surgery to maintain pupil dilation and reduce postoperative pain.
• RayPRO Free mobile and web-based digital platform that proactively collects Patient Reported Outcomes (PROs) over three years for RayOne IOL users.
• eyejourney AI Platform AI-based patient support and engagement platform for ophthalmic clinics featuring AI-generated videos with custom avatars, automated medication reminders, personalized messaging, and digital consent forms.
• OVDs (Ophthalmic Viscosurgical Devices) Ophthalmic viscosurgical devices used during cataract surgery to protect corneal endothelium and maintain space in the anterior chamber.
• AEON Family (Artificial Tears) Family of artificial tear products for eye care and dry eye treatment.
• Raytrace Biometry and calculation platform for intraocular lens power calculations supporting cataract and refractive surgery planning.
• Galaxy IOL System Intraocular lens system product line including preloaded injector options for cataract surgery.
• Duet Procedure (Sulcoflex Supplementary IOL) Supplementary IOL procedure combining Sulcoflex pseudophakic supplementary lens with primary IOL implantation for refractive enhancement.

Quantifiable outcome

• Up to 1.5D increased range of focus with emmetropic target
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• This AG (Swiss Ophthalmology Innovation)coreStrategic or Co-development Partner · 17 January 2024Rayner acquired This AG, a Swiss startup that developed the wireless Sophi phaco device for eye surgery. This acquisition expanded Rayner's product portfolio in cataract surgery technology and led to FDA 510(k) clearance for the Sophi phacoemulsification system.
• Professor Graham BarrettcoreStrategic or Co-development PartnerProfessor Graham Barrett collaborated with Rayner in developing the RayOne EMV increased range of focus IOL with patented non-diffractive optic profile.
• IMPACT Foundation BangladeshminorOthersRayner has supported IMPACT Foundation Bangladesh for over 20 years through regular donations of intraocular lenses (100 lenses per month) for use on the Jibon Tari floating hospital, helping restore sight to some of the world's poorest people in Bangladesh.
• InnoptixcoreTechnology or IntegrationInnoptix is Rayner's digital arm that developed the eyejourney AI-based patient education and engagement platform for ophthalmic clinics.
• BSI (British Standards Institution)minorOthersBSI Membership providing quality management system certification and standards compliance.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Alcon: Alcon is the world's largest ophthalmic medical device company, offering a comprehensive cataract surgery portfolio including PanOptix trifocal IOLs, ORA intraoperative aberrometry, and Centurion phaco systems. It directly competes with Rayner across nearly every product category but at vastly greater scale.
• Johnson & Johnson Vision: J&J Vision is a major ophthalmic device player through its TECNIS IOL family (Symfony, Odyssey, Eyhance), CATALYS phaco system, and iFS advanced femtosecond laser. It competes head-to-head with Rayner in premium IOLs and is investing heavily in extended-depth-of-focus technology.
• Bausch + Lomb: Bausch + Lomb offers the enVista IOL family, Stellaris Elite phaco system, and a broad surgical product portfolio. It competes directly with Rayner across cataract surgery IOLs and equipment, particularly in North America and Europe.

Direct peers

• HOYA Corporation: HOYA Surgical Optics offers the Vivinex and iSert preloaded IOL systems, competing directly with Rayner in the monofocal and toric IOL segments across Europe and Asia-Pacific. Similar mid-sized scale to Rayner.
• Beaver-Visitec International (BVI): BVI Medical manufactures and distributes ophthalmic surgical instruments, viscoelastic devices, and IOLs (including the PODEYE and IC-8 Apthera IOLs). It competes directly with Rayner's OVDs, surgical consumables, and premium IOL portfolio.
• Carl Zeiss Meditec: Zeiss Meditec offers the CT LUCIA and AT ELANA IOL families, Callisto eye surgical assistance systems, and OPMI Lumera microscopes. It is a comparable mid-to-large competitor in premium IOLs and surgical workflow tools for cataract surgeons.
• STAAR Surgical: STAAR Surgical specializes in Implantable Collamer Lenses (ICLs) for refractive surgery and silicone IOLs. While smaller and more focused on refractive lens exchange, it competes with Rayner's premium vision correction portfolio.

Emerging players

• Ocular Therapeutix: Ocular Therapeutix develops sustained-release ocular drug delivery including Dextenza for post-surgical inflammation. It is an adjacent competitor to Rayner's OMIDRIA pharmaceutical offering used during cataract surgery.
• RxSight: RxSight pioneered the Light Adjustable Lens (LAL), the first IOL that enables post-operative power adjustments using UV light. It represents a disruptive technology that could compete with Rayner's RayOne EMV in the premium IOL upgrade market.
• Lenstec Inc: Lenstec is a smaller IOL manufacturer focused on premium refractive IOLs including the SBL-3 bifocal and ClearView 3 multifocal lenses. It competes in the same premium IOL niche as Rayner's RayOne Trifocal and EMV products.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

• Xtwitter.com/rayneriol
• YouTubeyoutube.com/@Rayner.Global
• LinkedInlinkedin.com/company/rayner-iol
• Instagraminstagram.com/rayner.global

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries14 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rayner Surgical Group